Abstract:Silkworm (Bombyx mori L.) has a clear genetic background, parts of which are highly homologous to certain genes related to human hereditary diseases. Thus, the species presents an excellent interspecies model for drug screening and microbe-host interaction studies. Chloramphenicol (CAM) and vancomycin (VCM) are antibiotics commonly used to treat specific bacterial infections in medical care, animal husbandry, and agriculture. However, inappropriate dosages and prolonged therapy increase their risk of toxicity. In this work, we investigated the physiological and toxicological responses of silkworm to combined oral administration of CAM and VCM. Results showed that antibiotics promote the feeding behavior of silkworm and significantly reduce (P < 0.05) intestinal cultivable bacterial counts. Moreover, antibiotics decreased the antioxidant enzyme activities of superoxide dismutase, catalase, glutathione S-transferase, and thioredoxin reductase and caused oxidative damage to the silkworm intestine; the degree of damage was confirmed by histopathology analysis. The gene expression levels of antimicrobial peptides (attacin, lysozyme, and cecropins) were also perturbed by antibiotics. After antibiotic exposure, 16S rRNA metagenomic sequencing revealed increases in the relative abundance of Sphingobium, Burkholderia, Barnesiella, Bacteroides, Bradyrhizobium, Acinetobacter, Phenylobacterium, Plesiomonas, Escherichia/Shigella, and unclassified bacteria, as well as a reduction of Enterococcus. The metabolic and functional profiles of intestinal microbiota, particularly metabolic processes, such as energy, cofactors and vitamins, lipid, amino acid, and carbohydrate metabolisms, changed after antibiotic exposure. In conclusion, our findings reveal that antibiotics exert substantial effects on silkworm. The present study may promote the applications of silkworm as an interspecies model in the medical and pharmaceutical fields.

Silkworm model of bacterial infection facilitates the identification of lysocin E, a potent, ultra-rapid bactericidal antibiotic

Advantages of the Silkworm As an Animal Model for Developing Novel Antimicrobial Agents

Nosokomycins, new antibiotics discovered in an in vivo-mimic infection model using silkworm larvae. I: Fermentation, isolation and biological properties

Discovery of new AMR drugs targeting modulators of antimicrobial activity using in vivo silkworm screening systems

Silkworm larvae as an animal model of bacterial infection pathogenic to humans.

Pharmacokinetic parameters explain the therapeutic activity of antimicrobial agents in a silkworm infection model

A Novel Spiro-Heterocyclic Compound Identified by the Silkworm Infection Model Inhibits Transcription in Staphylococcus aureus

A Silkworm Infection Model for In Vivo Study of Glycopeptide Antibiotics

Effect of Vitamin A on Listeria monocytogenes Infection in a Silkworm Model

The Physiological and Toxicological Effects of Antibiotics on an Interspecies Insect Model

Antiviral Activity in the Mulberry Silkworm, Bombyx Mori L.

Enzyme-coated mesoporous silica nanoparticles as efficient antibacterial agents in vivo

Lactic acid bacteria activating innate immunity improve survival in bacterial infection model of silkworm.

Molecular mechanism and potential application of bacterial infection in the silkworm, Bombyx mori

The humoral immune response of the lepidopteran model insect, silkworm Bombyx mori L., to microbial pathogens

Specific Expression of Antimicrobial Peptides from the Black Soldier Fly in the Midgut of Silkworms (Bombyx mori) Regulates Silkworm Immunity

Identification of a Novel Broad-Spectrum Endolysin, Ply0643, with High Antibacterial Activity in Mouse Models of Streptococcal Bacteriaemia and Mastitis

A Novel Lysin Ply1228 Provides Efficient Protection Against Streptococcus Suis Type 2 Infection in a Murine Bacteremia Model.

An invertebrate infection model for evaluating anti-fungal agents against dermatophytosis

The Silkworm as a Source of Natural Antimicrobial Preparations: Efficacy on Various Bacterial Strains

Recent advances in the biosensors application for reviving infectious disease management in silkworm model: a new way to combat microbial pathogens